3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Phase 3
1
Status
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Observational
1
Sponsor
Cancer Type
Gynecologic
2
Head & Neck
1
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Breast Neoplasms
29
Neoplasms
12
Lung Neoplasms
11
Endometrial Neoplasms
11
Stomach Neoplasms
10
Lymphatic Metastasis
7
Head and Neck Neoplasms
7
Melanoma
6
Esophageal Neoplasms
6
Carcinoma, Hepatocellular
6
Uterine Cervical Neoplasms
5
Colonic Neoplasms
5
Carcinoma, Non-Small-Cell Lung
5
Rectal Neoplasms
4
Ovarian Neoplasms
4
Sarcoma
3
Prostatic Neoplasms
3
Lymphedema
3
Colorectal Neoplasms
3
Brain Neoplasms
3
Vulvar Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Solitary Pulmonary Nodule
2
Sarcoma, Ewing
2
Rhabdomyosarcoma
2
Peritoneal Neoplasms
2
Osteosarcoma
2
Multiple Pulmonary Nodules
2
Margins of Excision
2
Giant Cell Tumor of Bone
2
Interventions
Radiotherapy
9
Cisplatin
9
pembrolizumab
6
Methods
6
fludarabine
4
Papillomavirus Vaccines
4
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
4
Early Intervention, Educational
4
Cyclophosphamide
4
durvalumab
3
aldesleukin
3
Vaccines, Synthetic
3
Vaccines
3
Radiosurgery
3
Radiation
3
Platinum
3
Palliative Care
3
Paclitaxel
3
Nivolumab
3
Gemcitabine
3
Carboplatin
3
Brachytherapy
3
Bleomycin
3
1,2-diaminocyclohexaneplatinum II citrate
3
tremelimumab
2
lenvatinib
2
entinostat
2
aflibercept
2
Trastuzumab
2
Specimen Handling
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Interventional
×
Vulvar Neoplasms
×
Indocyanine Green
×
Clear all
NCT06871787
2025-03-14
INOCA
Istanbul University
Phase 4
Not yet recruiting
50 enrolled
NCT02997553
2023-01-09
GASVERT
Institut de Cancérologie de Lorraine
Phase 3
Completed
744 enrolled